Ready! Aim! Fire! targeting the right medical science journal
Conclusion: Our work suggests that little attention has been focused in the scientific literature on the mechanisms that authors use to select a journal for their work. Nevertheless, scientists for the most part seem to have a good sense of where their papers are most likely to be accepted. Beyond ensuring that a manuscript fulfils all the target journal’s requirements, the literature suggests that it is important to have an objective view of the scientific contribution or ‘value’ of your work. (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - August 18, 2017 Category: Cardiology Tags: Original articles Source Type: research
Metformin: new insights into an archetypal cardiometabolic drug
No abstract available (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - August 18, 2017 Category: Cardiology Tags: Editorial Source Type: research
Effect of vitamin D status on lipid profile in premenopausal women: a cross-sectional study
Conclusion: There may be an association between vitamin D insufficiency and dyslipidemia. However, this association may depend on obesity. (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - May 12, 2017 Category: Cardiology Tags: Original articles Source Type: research
Prevalence of high-risk cardiovascular patients with therapy-resistant hypercholesterolemia
Conclusion: The prevalence of high-risk cardiovascular patients with therapy-resistant hypercholesterolemia is substantial in Germany. (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - May 12, 2017 Category: Cardiology Tags: Original articles Source Type: research
Factors affecting the haemodynamic behaviour of patients undergoing pheochromocytoma and paraganglioma removal: A review
Pheochromocytoma and paraganglioma are catecholamine-secreting tumours associated with major haemodynamic upheavals. The cardiovascular and other organ-related morbidity and even mortality has been ascribed to the major haemodynamic effects of these tumours. Many factors affect the nature and intensity of these haemodynamic changes. The rarity of these tumours as well as their extremely varied clinical presentation preclude conduct of randomized-controlled trials that may provide evidence in terms of these factors and the ways to predict and control them. Many retrospective studies and case reports, however, do provide som...
Source: Cardiovascular Endocrinology - May 12, 2017 Category: Cardiology Tags: Review articles Source Type: research
Nonalcoholic fatty liver disease: implications for cardiovascular risk
Nonalcoholic fatty liver disease (NAFLD) is a growing epidemic in the USA affecting ∼30% of the population. It has been closely linked to metabolic syndrome and type 2 diabetes, with strong implications for cardiovascular disease (CVD). This review focuses on the relationship between NAFLD and CVD and the proposed interactions interlinking these two diseases. This appraisal also discusses treatments targeting NAFLD in the context of CVD. NAFLD is a multisystem disease and ultimately the goals of therapy are to ameliorate CVD and prevent coronary artery disease morbidity and mortality. (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - May 12, 2017 Category: Cardiology Tags: Review articles Source Type: research
Pioglitazone and cardiovascular risk reduction: time for a second look?
Insulin resistance, a fundamental pathophysiological abnormality in patients with type 2 diabetes, is associated with increased cardiovascular (CV) disease risk. In diabetes management, the macrovascular impact of antihyperglycemic agents that do not improve insulin sensitivity has generally been disappointing. In contrast, glucose-lowering drugs that work as insulin sensitizing agents have been postulated to reduce CV complications. The data to support this hypothesis have, however, been inconsistent. The impact of thiazolidinediones on macrovascular events is of particular interest. In this review, we discuss the results...
Source: Cardiovascular Endocrinology - May 12, 2017 Category: Cardiology Tags: Review articles Source Type: research
‘Knowing what Matters in diabetes: Healthier below 7’: results of the campaign’s first 10 years (part 2), participants without known diabetes history
Conclusion: The data collected in individuals without a known history of diabetes indicate a considerable prevalence of typical risk factors associated with diabetes. In addition, the data confirmed that screening of apparently healthy individuals consistently shows a significant proportion of individuals with previously undetected type 2 diabetes which, in the subgroup, was surprisingly high. As there is convincing evidence for the beneficial effect of relatively simple lifestyle interventions such as an increase of physical activity and avoidance of unfavourable diets, and weight reduction, campaigns such as ‘Knowing w...
Source: Cardiovascular Endocrinology - February 16, 2017 Category: Cardiology Tags: Original Article Source Type: research
Cardiometabolic prevention in Romania: a midsummer night’s dream?
No abstract available (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - February 16, 2017 Category: Cardiology Tags: Around the World Source Type: research
Editorial
No abstract available (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - February 16, 2017 Category: Cardiology Tags: Editorial Source Type: research
A review of the evidence for alternative and complementary medical approaches in the prevention of atherosclerotic cardiovascular disease and diabetes
The use of complementary and alternative medicine approaches has increased in the recent years. It has been utilized in both the treatment and prevention of many chronic diseases, especially in the management of hypertension, diabetes, and hyperlipidemia. Lifestyle modifications play a fundamental role in alternative and complementary medicine. Regular exercise, maintenance of optimal weight, and a healthful diet play vital roles in maintaining ideal health. Specifically, the Dietary Approaches to Stop Hypertension and Mediterranean diets have been established as having beneficial effects on blood pressure and cholesterol ...
Source: Cardiovascular Endocrinology - February 16, 2017 Category: Cardiology Tags: Review Articles Source Type: research
Hypertension in diabetes and the risk of cardiovascular disease
Hypertension (HTN) is an important risk factor for cardiovascular disease and its many manifestations. It shares pathogenic pathways with diabetes and is part of a common metabolic entity, the metabolic syndrome. When combined with diabetes, HTN has been shown to predict and promote increased risk for cardiovascular disease events over and above each risk factor alone. Of the components of this metabolic syndrome, HTN is relatively easy to diagnose and thereby more accessible for implementing preventive and treatment strategies. The recent release of Joint National Committee-8 guidelines for the treatment of HTN has fueled...
Source: Cardiovascular Endocrinology - February 16, 2017 Category: Cardiology Tags: Review Articles Source Type: research
Dyslipidemia in diabetes mellitus and cardiovascular disease
Patients with diabetes have a high residual risk for cardiovascular disease (CVD) and adverse outcomes despite statin therapy and lifestyle modifications. Particular to individuals with diabetes is the pattern of elevated triglycerides, small dense low density lipoprotein cholesterol, and reduced levels of high density lipoprotein cholesterol, described as dyslipidemia of diabetes. The role of combination therapy with an additional agent such as niacin, ezetimibe, fenofibrate, and n-3 fatty acids has been studied; however, at the same time, these agents have come under criticism for their limitations. We performed a review...
Source: Cardiovascular Endocrinology - February 16, 2017 Category: Cardiology Tags: Review Articles Source Type: research
Metabolically healthy versus unhealthy obesity and risk for diabetes mellitus and cardiovascular diseases
Obesity presents one of the biggest issues of modern-day life for a wide variety of medical specialties, starting with the cardiologist and ending with the diabetologist or the bariatric surgeon. However, in the last few years a new entity has emerged, the metabolically healthy obese (MHO) individual. This category encompasses obese individuals without the presence of metabolic diseases such as type 2 diabetes mellitus, dyslipidemia, or hypertension. Several studies have thus been undertaken to determine the risk of these MHO individuals for diabetes mellitus or cardiovascular diseases compared with the ‘unhealthy’ obe...
Source: Cardiovascular Endocrinology - February 16, 2017 Category: Cardiology Tags: Review Articles Source Type: research
Cardiovascular risk assessment and screening in diabetes
Diabetes used to be considered as a coronary heart disease equivalence and universally classified high cardiovascular risk population. However increasing epidemiological evidence now indicates the heterogeneity of risk among the diabetic patients and imposes animportance of stratifying those with relative low-risk from high-risk ones. Despite the existing risk assessment tools, current cardivoascualr disease prevention guidelines fail to provide more detailed stratification strategies for patient with diabetes and expose them to either overtreatment or undertreatment. On the other hand, various screening modality, includin...
Source: Cardiovascular Endocrinology - February 16, 2017 Category: Cardiology Tags: Review Articles Source Type: research
